Tetrapeptide adamantyl amides

Chemistry of carbon compounds – Miscellaneous organic carbon compounds – C-metal

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

2601125R, C07C10352

Patent

active

045143323

ABSTRACT:
This invention relates to novel tetrapeptide adamantyl amides that are useful in the treatment of hypertension.

REFERENCES:
patent: 4273704 (1981-06-01), Mazur
Goodman and Gilman, The Pharmacological Basis of Therapeutics, (New York, 1975), Fifth Edition, Chaps. 26, 27, 28, 30, 33, 39, 40.
Poulsen, Burton, and Haber, "Competitive Inhibitors of Renin; Biochemistry, 12, 3877-3882 (1983).
Burton, Cody, Herd, and Haber, "Specific Inhibition of Renin by An Angiotensinogen Analog . . . ", Proc. Natl. Acad. Sci. USA, 77, 5476-5479, (1980).
Cody, Burton, Evin, Poulsen, Herd, and Haber, "A Substrate Analog Inhibitor of Renin That Is Effective In Vivo," Biochem. Biophys. Res. Commun., 97, 230-235, (1980).
Burton, Poulsen, and Haber, "Competitive Inhibitors of Renin . . . ", Biochemistry, 14, 3892-3898, (1975).
Haas, Lewis, Scipione, and Koshy, "Micromethod for the Assay of Renin of Seven Species," Hypertension, 1, 112-117, (1979).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Tetrapeptide adamantyl amides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tetrapeptide adamantyl amides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrapeptide adamantyl amides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1967329

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.